Abstract
The aim of the present study is to develop and formulate a nanoparticulate carrier for sustained and ocular delivery of Fluconazole and to study its in-vitro release characters. Chitosan nanoparticles of Fluconazole were formulated by spontaneous emulsification and cross-linking method. The mean particle size, drug loading capacity, invitro release profile and release kinetics were studied. The antifungal efficacies of nanospheres were compared with conventional eye drops by cup-plate method. The average particle size was found to be 152.85±13.7nm. The drug loading capacity of all drug loaded nanoparticles was found to be optimum (≤50%). The in-vitro release study revealed the zero order kinetics and Higuchi’s diffusion mechanism. The drug bound nanoparticles exhibited good in-vitro antifungal effect in comparison with conventional eye drops. The formulated nanoparticles were found to be a suitable carrier for sustained ocular delivery of Fluconazole in terms of optimum drug loading, sustained release characters and antifungal activity.
Keywords: Chitosan, fluconazole, nanoparticles, ocular, sustained release.
Nanoscience & Nanotechnology-Asia
Title:In-vitro Characterization of Chitosan Nanoparticles of Fluconazole as a Carrier for Sustained Ocular Delivery
Volume: 7 Issue: 1
Author(s): Kumaraswamy Santhi, Selvadurai Muralidharan, Young H. Yee, Fong Y. Min, Chong Z. Ting and Durga Devi
Affiliation:
Keywords: Chitosan, fluconazole, nanoparticles, ocular, sustained release.
Abstract: The aim of the present study is to develop and formulate a nanoparticulate carrier for sustained and ocular delivery of Fluconazole and to study its in-vitro release characters. Chitosan nanoparticles of Fluconazole were formulated by spontaneous emulsification and cross-linking method. The mean particle size, drug loading capacity, invitro release profile and release kinetics were studied. The antifungal efficacies of nanospheres were compared with conventional eye drops by cup-plate method. The average particle size was found to be 152.85±13.7nm. The drug loading capacity of all drug loaded nanoparticles was found to be optimum (≤50%). The in-vitro release study revealed the zero order kinetics and Higuchi’s diffusion mechanism. The drug bound nanoparticles exhibited good in-vitro antifungal effect in comparison with conventional eye drops. The formulated nanoparticles were found to be a suitable carrier for sustained ocular delivery of Fluconazole in terms of optimum drug loading, sustained release characters and antifungal activity.
Export Options
About this article
Cite this article as:
Santhi Kumaraswamy, Muralidharan Selvadurai, Yee H. Young, Min Y. Fong, Ting Z. Chong and Devi Durga, In-vitro Characterization of Chitosan Nanoparticles of Fluconazole as a Carrier for Sustained Ocular Delivery, Nanoscience & Nanotechnology-Asia 2017; 7 (1) . https://dx.doi.org/10.2174/2210681206666160402003316
DOI https://dx.doi.org/10.2174/2210681206666160402003316 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy
Current Drug Targets Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
Current Vascular Pharmacology Nitrogen-Containing Bisphosphonates and Cancer Immunotherapy
Current Pharmaceutical Design Osteocyte biology and space flight
Current Biotechnology miRNA Functions in Arthritis
Current Rheumatology Reviews Effects of a Hypocaloric Diet on Obesity Biomarkers: Prevention of Low-Grade Inflammation since Childhood
Current Pharmaceutical Design NGAL is a Precocious Marker of Therapeutic Response
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension
Current Hypertension Reviews Crohns Targeted Therapy: Myth or Real Goal?
Current Drug Discovery Technologies Editorial [Hot Topic: New Approaches to Treating Cancer: Medicinal Chemistry and Therapeutic Potential (Guest Editor: David J. Weber)]
Current Topics in Medicinal Chemistry Cell Death and microRNAs in Cholestatic Liver Diseases: Update on Potential Therapeutic Applications
Current Drug Targets Paeonol, a Powerful Natural Product with Broad Biological Spectra by Inhibiting Inflammatory Pathway
Current Traditional Medicine Emerging Role of microRNA in Neuropathic Pain
Current Drug Metabolism Metabolomics as a Tool for Drug Discovery and Personalised Medicine. A Review
Current Topics in Medicinal Chemistry Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Substance P: Structure, Function, and Therapeutics
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Proteomics Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol
Current Pharmaceutical Biotechnology Editorial: Inflammasomes – In Health and Diseases
Inflammation & Allergy - Drug Targets (Discontinued)